Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Atorvastatin in Hospitalized COVID-19 Patients: A Randomized, Double-blinded, Placebo-Controlled, Clinical Trial

NCT04952350 is registered in ClinicalTrials.gov with Mansoura University as lead sponsor.

NCT NCT04952350
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04952350 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Atorvastatin in Hospitalized COVID-19 Patients: A Randomized, Double-blinded, Placebo-Controlled, Clinical Trial
Lead sponsor
Mansoura University
Phase
Phase 3
Overall status
Unknown status
Start date
August 14, 2021
Completion date
April 30, 2022
Enrollment
220 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 pneumonia, covid19, sars-cov2 infection